Where Oncology Pharmacists, Residents, & Technicians access Chemotherapy Drug Information, Products, & Programs
OncologyPharmacist.NET is dedicated to providing timely information, consulting services, and links for Clinical Hem/Onc/BMT Pharmacists, Residents, and Technicians, in a single location, to be used on a daily basis. Improving Patient Care through the exchange of information is our goal. Our News and Clinical Tools sections will come from practice sites throughout the world. Our Job Boards will focus on relevant positions exclusively. Our Patient Assistant Programs area will link to sites that provide drugs that are used strictly in Hematology and Oncology. New Drugs will highlight Chemotherapy and Supportive Care drugs with new indications within the last 365 days. Our hope is to integrate CMS coding and announcements in the future as well as provide an area for Hem/Onc/BMT Residents, Technicians, and Practitioners to exchange ideas. Please bookmark our site, sign up to be listed on our Advisory Board Clinicians or Speakers List, send us suggestions or guidelines to improve the site, and consider advertising in this exciting domain. OP
NewsfeedCancer / Oncology News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.
Researchers identify new molecular marker for killer cells
Cell marker enables prognosis about the course of infectionsWhen a pathogen invades the body, specific cells in the human immune system are ready to take immediate action in order to destroy it.
Preventing cancer: Study finds dramatic benefits of weight-loss surgery
Tremendous changes seen in women most at risk for cancerIN A NUTSHELL:A study looked at the effects of weight-loss surgery on obese women most at risk for cancer.
Fatty liver disease and scarring have strong genetic component
Researchers at the University of California, San Diego School of Medicine say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases...
Gene therapy doubles survival in recurrent glioblastoma
San Antonio's Cancer Therapy & Research Center led Phase 2 testing of new agentAn experimental gene therapy essentially doubled the overall survival of patients with recurrent glioblastoma...
Rising cancer rates in low and middle income countries threaten economic stab...
The rising cost of treating and caring for a growing number of cancer patients threatens economic development in low and middle income countries (LMICs), making prevention a key element of health...
Newsfeed display by CaRP
|Headquarters: Warwick, RI • ©2009 OncologyPharmacist.net|